Search Results for:

Home


About


Our Business

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (“FDF”) and active pharmaceutical ingredients (“APIs”). Our focus...


Innovation


India

[vc_row][vc_column width="1/2"][vc_column_text]At NATCO, we hold a leading market share in the oncology segment amongst Indian companies. Over the years, backed by our strong R&D capabilities, we have been able to launch many targeted therapy...


People


Investors


Responsibility


Locations

Natco Pharma Limited Registered Office and Corporate Headquarters Natco House Road No.2, Banjara Hills Hyderabad-500 034, India +91-40-2354 7532 +91-40-2354 5298/23548243 www.natcopharma.com


Responsibility


People


Investors


Innovation


Our Business


About


Mission & Heritage


Our Strengths


Management


Facilities

Headquartered in Hyderabad, India, Natco has five formulation locations across India – two in Dehradun (Uttarakhand), one in Kothur (Mahboobnagar, Telangana), one in Nagarjuna Sagar (Nalgonda Dist, Telangana), and one in Guwahati (Assam); two...


News & Announcements


Domestic Formulations


International Formulations

NATCO has over 30 years of expertise in formulating innovative dosage forms. NATCO today is leveraging on this expertise to go global by exporting finished dosage products to various markets across the globe. Our partnership-driven business model...


Active Pharmaceutical Ingredients

Natco has proven technical and operational expertise of over two decades in developing and commercialising niche APIs. Our unwavering commitment to quality; cGMP compliance to deliver affordable drug substances with novelty, and improving market...


Contract Manufacturing

Natco is well recognized as a high quality contract manufacturing company to many leading pharmaceutical firms in India.  This is supported at Natco by its high inclination towards quality systems and state-of-the-art facilities.  Natco currently...


Blockbusters


Oncology - Hematology

NATCO’s domestic oncology division deals with haemato-oncology and solid tumor products. These product portfolios consist of molecules that are of decisive therapeutic importance in cancers of blood, liver, kidney, lung, brain, breast, ovary...


Oncology - Solid Tumors

NATCO’s domestic oncology division deals with haemato-oncology and solid tumor products. These product portfolios consist of molecules that are of decisive therapeutic importance in cancers of blood, liver, kidney, lung, brain, breast, ovary...


Speciality Pharma

The Pharma specialities division deals with products related to Orthopaedics and Gastroenterology. The orthopaedics range covers all the important Bisphosphonates, including the oral and injectable drugs. All of them are segment first introductions...


QIP 2017

Disclaimer - Important THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED IN THE UNITED STATES. THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE BY NATCO PHARMA LIMITED (THE “COMPANY”) TO COMPLY WITH...


Terms of Use

Welcome to the Natco Pharma Limited web site. The information provided on this site is for general information and business purposes only. Please read and review these Terms and conditions carefully before accessing or using this Web site. By...


Privacy Policy

We, Natco Pharma Limited, adopted this Privacy Policy with respect to collection, use, storage and disclosure of personal information gathered by us in ordinary course of business. We respect the privacy of visitors to this Web site and understand...


Generic Research

Innovative Process Research Novel Chemistry Novel Routes of Synthesis. Process elegance. Cost Effective Technology Development Technology indigenization Import substitution. Commercial plant compliance. Green & Safe...


New Drug Discovery

New Drug Discovery (Medicinal Chemistry division): Natco works for the patient. The core philosophy of Natco’s drug discovery program is to focus on the unmet needs of patients, especially in areas of cancer and make specialty medicines available...


Intellectual Property

IP Management In-House management of generation/identification & protection. Coordination during patent prosecution. Patent vigilance on competitor applications. Coordination of local/global patent litigation.


Analytical

Analytical R&D capabilities at Natco: The Analytical R & D (ARD) caters to API, Formulations development for generics as well as NCEs. The ARD has ability to support small molecules, peptides and non-biological complex drugs. We also have...


Opportunities

Collaborative research & development Institutional Collaboration. Contract Research. Specialty Synthetic & Analytical services. Contract process development & scale-up. Co-development of NCEs & partnerships New Drug Discovery areas. NCE...


Meet Our People

At Natco we strongly believe that our employees are an integral part of our growth story and value them as our most important asset. Here are a few short excerpts from our employees, talking about what it’s like to work at Natco.


Careers

The Natco family currently consists of over 4000 employees. We provide a stimulating and challenging work environment to our employees, who get the opportunity to work on state-of-the-art technologies and deliver affordable and life saving drugs to...


Environment, Health & Safety

Natco believes that sustainable development, in any environment, has to be a participatory process, with employees and local population, being the biggest stakeholder. We work closely with the local community to keep the air, water and land both...


Certification & Awards

Our facilities are WHO compliant and approved by other global regulatory bodies. We have been progressively establishing ISO14001:2004 compliant Environmental Management System and OHSAS-18001:2007 compliant Occupational Health and Safety Management...


Natco Trust

The objective of the award winning Natco Trust, the corporate social responsibility wing of Natco Pharma Limited (founded 1995), is to repay society, people and the environment. Over the years, the Trust has widened its coverage in line with the...


Stocks


Shareholder Information


CSR Policy


Annual Reports


IR and Shareholder Contacts

  For Institutional Investors & Research Analysts Mr. Rajesh Chebiyam Vice President- Investor Relations & Business Development PH: +91-40-23547566 Email: ir@natcopharma.co.in For Retail...


Sitemap

[pagelist]


E-Voting Results AGM 2015


Scheme of Amalgamation


Investor Presentation

This presentation contains forward-looking statements and information that involve risks, uncertainties and assumptions. Forward-looking statements are all statements that concern plans, objectives, goals, strategies, future events or performance...


Statutory Communications


Shareholding Pattern


Shareholder Information


Corporate Governance & Policies


search


Unclaimed Dividend

Dear Shareholders, As you may be aware, the Ministry of Corporate Affairs (MCA) on May 10, 2012 vide reference no. G.S.R_352(E) notified the Investor Education Protection Fund (Uploading of information regarding unpaid and unclaimed amounts lying...


API Mekaguda

API Facility, Mekaguda Plant Location Natco Pharma Limited Chemical Division, Mekaguda (Village), Nandigama (Mandal), Rangareddy  District, Telangana - 509 223, India. Capacity Current Plant capacity: 398 KL Up coming Plant...


API Chennai

API Facility, Chennai Plant Location Natco Pharma Limited, Chemical Division, No-74/B, Vaikkadu TPP Salai, Manali, Chennai – 600 103, India. Capacity Current Plant capacity: 9.5 kgs / month of various Cytotoxic API’s and...


Formulations Kothur

Formulations Facility, Kothur Plant Location Natco Pharma Limited, Kothur (Post), Kothur (Mandal), Rangareddy District, Telangana - 509 228, India Plant Size Over All Plant Area: 17 Acres Built-Up Area: 4.3...


Formulations Nagarjuna Sagar

Formulations Facility, Nagarjuna Sagar Plant Location Natco Pharma Limited, Pharma Division - Parenterals , Vijayapuri North, Nagarjuna Sagar, Peddavura mandal, Nalgonda District - 508 202, Telangana, India Plant Size Total...


Formulations Dehradun Unit 6

Formulations Facility, Dehradun Unit 6 Plant Location Natco Pharma Limited, Plot No.: 19, Pharma City, Sidcul, Selaqui, Dehradun – 248 197, Uttarakhand, India. Plant Size Total Land Area: 2.14 Acres Built-Up Area: 0.9...


Formulations Dehradun Unit 7

Formulations Facility, Dehradun Unit 7 Plant Location Natco Pharma Limited, Plot No. : A3, Upsidc Ind.Area, Selaqui, Dehradun – 248 197, Uttarakhand, India. Plant Size Total Land Area: 2.5 Acres Built-Up Area: 0.6...


Formulations Guwahati

Formulations Facility, Guwahati Plant Location Dag No. 749, 750, Vill: Kokjhar, Mirza, Guwahati – 781 125, Assam, India. Plant Size Total Land Area: 2.1 Acres Built-Up Area: 0.8 Acres Regulatory...


Research Center (NRC)

Research Center (NRC) Location B-11, Industrial Estate Sanathnagar, Hyderabad Telangana-500 018. Capacity – Synthetic chemistry – Biotech & fermentation – Nano pharmaceuticals – New Drug Discovery – Animal...


Corporate Office

Corporate Office Location Natco House, Road No.2, Banjara Hills, Hyderabad-500 034, India. Number of Employees: 218...


Contract Manufacturing Facility Nagarjuna Sagar

Contract Manufacturing Facility, Nagarjuna Sagar Plant Location Natco Pharma Limited-Pharma Division - Parenterals, Vijayapuri North, Nagarjuna Sagar, Nalgonda District Telangana-508 202. India. Regulatory...


Contract Manufacturing Dehradun Unit 6

Contract Manufacturing Facility, Dehradun Unit 6 Plant Location Natco Pharma Limited - Pharma Division, Plot No. 19, Pharma City Selaqui Industrial Area, Vikas Nagar Dehradun-248 001, India. Regulatory Approvals WHO...


Contract Manufacturing Dehradun Unit 7

Contract Manufacturing Facility, Dehradun Unit 7 Plant Location Natco Pharma Limited, Plot No: A-3, Upsidc Indl.Area, Selaqui, Dehradun – 248 197, India. Regulatory Approvals WHO GMP EU GMP Number of...


Sustainability Report


Financials

  Quarterly Results  Quarterly Results 2019 - 2020 Transcripts - Earnings Call 2019 – 2020 Quarter 1 report for the year 2019 – 2020 Q1 FY20 Earnings Conference Call - Transcript    Quarterly Results...


Buy back

Natco Pharma Limited has informed the Exchange that the board of directors of the Company, at its meeting held November 5, 2018, have approved the buyback of fully paid-up equity shares of face value of Rs. 2/- (Rupees Two only) each of the Company...


Oncology

NATCO’s domestic oncology division deals with haemato-oncology and solid tumor products. These product portfolios consist of molecules that are of decisive therapeutic importance in cancers of blood, liver, kidney, lung, brain, breast, ovary...


Certification & Awards

Our facilities are WHO compliant and approved by other global regulatory bodies. We have been progressively establishing ISO14001:2004 compliant Environmental Management System and OHSAS-18001:2007 compliant Occupational Health and Safety Management...


Business Responsibility Policies

ETHICS, TRANSPARENCY AND ACCOUNTABILITY PRODUCT LIFE CYCLE SUSTAINABILITY EMPLOYEE WELL – BEING STAKEHOLDER MANAGEMENT HUMAN RIGHTS ENVIRONMENT EQUITABLE...


Investors Education Protection Fund (IEPF)

Dear Shareholders, Pursuant to Section 124(6) of the Companies Act, 2013 all shares in respect of which dividend remained unpaid or unclaimed for seven consecutive years or more, shall have to be transferred by the company to the demat account of...


Formulation Visakhapatnam

Formulations Facility, Visakhapatnam Plant Location Natco Pharma Limited, Plot no. 89 & 90, SEZ, J N Pharma City, Parawada, Visakhapatnam District, Andhra Pradesh 531019. Capabilities Cytotoxic & other Oral Solid...


Contact us


Contact


Contact


Markets Overview

Natco products reach more than 40 countries globally. Key geographies include India, North America, Latin America, Asia Pacific, South East Asia & Middle East.Through our partneship driven model, our exports are primarily done by out-licensing...


International

Natco products reach more than 40 countries globally. Key geographies include India, North America, Latin America, Asia Pacific, South East Asia & Middle East.Through our partneship driven model, our exports are primarily done by out-licensing...


Markets


Subsidiary Accounts

Natco Pharma Inc Financial Report FY 2018-19 View PDF Financial Report FY 2017-18 View PDF Financial Report FY 2016-17 View PDF Financial Report FY 2015-16 View PDF Financial Report FY 2014-15 View PDF Time Cap Overseas...


Subsidiary Accounts


Cardiology and Diabetology

NATCO has launched Cardiology and Diabetology (CnD) division (in early 2017), keeping in mind our mission of making specialty medicines accessible to all. Our current portfolio of products include: The anti diabetics range which offers one of...


Financials


News & Announcements


News & Announcements


financials


Corporate Governance Certificate


Corporate Governance Certificate